APC and colorectal cancer: In colorectal cancer, over 90% of the cases carry at least one mutation in genes involved in this pathway such as inactivating mutations of the adenomatous polyposis coli (APC) gene (~80%) and activating mutations of the β-catenin (CTNNB1) gene (~5%)2.